The Alzheimer's beta A4-amyloid protein precursor (APP) and the APP-li
ke proteins (APLPs) are transmembrane glycoproteins with a similar mod
ular domain structure. Alternatively spliced exons found in both genes
comprise a Kunitz protease inhibitor domain encoding exon, and anothe
r exon within the divergent regions adjacent to the transmembrane doma
in, i.e. exon 15 of the APP gene and an exon encoding 12 residues in A
PLP2. Omission of the latter exons in L-APP and L-APLP2 isoforms, resp
ectively, generates a functional recognition sequence for xylosyltrans
ferase-mediated addition of glycosaminoglycans and proteoglycan format
ion. In this paper, we summarize our analyses of the regulated express
ion of these alternatively spliced exons in APP and APLP2 in primary c
ultured rat brain cells, rat brain development and aging. In conjuncti
on with additional data for the human brain, these data provide import
ant clues for understanding the functional significance of alternative
splicing and glycosylation in APP biology. On the basis of recent res
ults showing a higher amyloidogenicity of exon 15 encoding APP than L-
APP isoforms, we further discuss the potential significance of the low
levels of LAPP in neurons for the susceptibility of the brain towards
Alzheimer's disease.